Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target.

byBenzinga Newsdesk

February 22, 2023

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target.

Brown & Brown Raises Quarterly Dividend From $0.1025 To $0.1150

By Michael Horton

October 18, 5:31 PM

Brown & Brown, Inc. (NYSE:BRO) announces that the board of directors has declared a regular quarterly cash dividend of $0.1150 per share. The dividend is payable on November 16, 2022, to shareholders of

BRO

What’s Sending Snap Stock Higher Today?

By Adam Eckert

March 16, 8:32 AM

Snap Inc (NYSE: SNAP) shares are trading higher Thursday following multiple reports that TikTok could face a ban if owners don't divest.

Travelzoo’s Business Model Reimagined Post-Pandemic: Analyst Upgrades Stock

By Shivani Kumaresan

April 28, 2:49 PM

Barrington Research analyst James C.Goss upgraded Travelzoo (NASDAQ:TZOO) from Market Perform to Outperform with a price target of $10. A positive byproduct…

TZOO

News

What’s Going On With Facebook (Meta Platforms) Stock

By Henry Khederian

April 28, 10:42 AM

Meta Platforms Inc (NASDAQ: META) shares are trading higher by 11.07% to $237.16 on a week-to-date basis. The company reported better-than-expected first-quarter results and an increase in active users. What Happened With META Earnings?

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

Related Posts

Brown & Brown Raises Quarterly Dividend From $0.1025 To $0.1150

What’s Sending Snap Stock Higher Today?

Travelzoo’s Business Model Reimagined Post-Pandemic: Analyst Upgrades Stock

What’s Going On With Facebook (Meta Platforms) Stock